Renova Therapeutics
Vijay Mahant is the President and CEO of Renova Therapeutics, working in gene therapy for Congestive Heart Failure, NASH, and Type-2 Diabetes. Prior to this role, Mahant served as the Founder and CEO of MediLite Diagnostika, focusing on ultra-sensitive technology for molecular and immuno-diagnostics. Vijay holds a MS and PhD from Loughborough University.
This person is not in any teams
This person is not in any offices
Renova Therapeutics
Renova Therapeutics is an industry leader in the emerging field of gene therapy, pursuing the development of treatments for congestive heart failure and other chronic diseases.We are committed to the highest standards in all we do and focus on treatments that can have an enormous impact on a global scale